Weed Week: Aurora Marijuanis and CBD bubble tea in Thailand

ICYMI, a mysterious pink light above Mildura, enthused its inhabitants last week with theories ranging from discontinuities in the space-time continuum to solar flares and aliens. But it was actually light from local medical cannabis facility Cann Group (ASX: CAN), which was producing marijuana that looked a bit like Aurora Borealis.

As you may know, cannabis grows in longer days,” CEO Peter Kroc told ABC’s Mildura Swan Hill Breakfast. 7:00 p.m. to 7:00 p.m.” “Usually the blackout blinds close as soon as the sun sets, but last night the lights were on and the blinds weren’t closed yet so the light had time to come in.” Crock said the facility’s brilliance is unique.

Also Read: Dr. Anthony Fauci’s Net Worth; How Wealthy Is The Covid Doctor? Awards and Honors

Thailand Breaks Out The CBD Bubble Tea

Last year, Thailand allowed cannabis extracts and leaves to be used in cosmetics, food, and beverages, and last month decriminalized personal consumption and the cultivation of the whole plant.

And companies are heating up in desserts, bubble tea, and skincare. Bangkok dessert shop Kanomsiam adds dried cannabis leaves to traditional panda-flavored pancakes for 170 baht (or $6.65).

A Total Of 17 Companies Were In The Green, With 10 Companies Flat And 10 Stocks In The Red.


CAU	Cronos Australia	0.29	142%	7%	21%	45%	$146,370,009.37
NTI	Neurotech Intl	0.088	66%	80%	26%	24%	$60,002,124.84
MRG	Murray River Grp	0.245	32%	0%	0%	0%	$10,808,210.04
EMD	Emyria Limited	0.215	19%	-40%	19%	-2%	$56,375,506.15
RNO	Rhinomed Ltd	0.19	1%	-25%	58%	15%	$51,429,544.92
BOT	Botanix Pharma Ltd	0.078	0%	32%	34%	7%	$73,442,503.80
CAN	Cann Group Ltd	0.31	-6%	13%	29%	-2%	$106,574,685.39
AVE	Avecho Biotech Ltd	0.014	-18%	8%	0%	17%	$24,810,469.10
IHL	Incannex Healthcare	0.21	-18%	-51%	-21%	0%	$256,466,805.60

Also Read: Pattaya to host cannabis festival in September

ASX WEED STOCKS

The company recently closed a $2 million secured line of credit from the National Australia Bank and sold its hemp food and wellness business to Ananda Food, a subsidiary of Ecofibre Limited (ASX: ECO), for $250,000 (plus inventory). increase.

Additionally, the company said the sale of its Tasmanian medicinal cannabis facilities and farms has begun “with high interest”. The idea is that most of the non-dilutive funds raised through debt financing, asset sales, and cost reductions will be invested in expanding medical cannabis production.

MD Nan-Maree Schoerie said: “We are about to begin a Phase 3 expansion aimed at doubling the safe growing acreage and leveraging available funding to introduce more protective growing capacity.”

Incannex has received ethical approval to initiate a Phase 1 clinical trial of its anti-inflammatory drug IHL-675A. This study will be conducted at CMAX Clinical Research in Australia and will evaluate the pharmacokinetics, safety, and tolerability of combination cannabinoid drugs.

The company said the study data will apply to all three of his IHL-675A development programs, rheumatoid arthritis, inflammatory bowel disease, and pneumonia. Patient recruitment is expected to begin in August 2022.